CompletedNCT00181935
Risperidone compared with olanzapine for mania in preschool children with bipolarity
About this title
Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder
Read the official source — NCT00181935Medication studyAges 4–6United States
Understand this study
Who was this study for?
Listed age limits: 4 years to 6 years.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateMarch 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 4 Years to 6 Years
- Official registry ID
- NCT00181935
- Official title
Show the full official title
Open-Label Comparative Study of Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Spectrum Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including risperidone (Risperdal) and olanzapine (Zyprexa).
Who was this study for?
Listed age limits: 4 years to 6 years.
